440
Participants
Start Date
August 26, 2013
Primary Completion Date
December 31, 2031
Study Completion Date
December 31, 2031
Intensity-Modulated Radiation Therapy
Undergo IMRT
Intensity-Modulated Radiation Therapy
Undergo IMPT
Laboratory Biomarker Analysis
Correlative studies
Photon Beam Radiation Therapy
Undergo IMRT
Proton Beam Radiation Therapy
Undergo IMPT
Quality-of-Life Assessment
Ancillary studies
New York Proton Center, New York
Memorial Sloan Kettering Cancer Center, New York
University of Pennsylvania/Abramson Cancer Center, Philadelphia
University of Maryland/Greenebaum Cancer Center, Baltimore
Inova Schar Cancer Institute, Fairfax
Emory University Hospital/Winship Cancer Institute, Atlanta
University of Florida Health Science Center - Gainesville, Gainesville
Miami Cancer Institute, Miami
University of Alabama at Birmingham, Birmingham
Wayne State University/Karmanos Cancer Institute, Detroit
Mayo Clinic in Rochester, Rochester
Northwestern Medicine Cancer Center Warrenville, Warrenville
Willis-Knighton Medical and Cancer Center, Shreveport
University of Oklahoma Health Sciences Center, Oklahoma City
M D Anderson Cancer Center, Houston
MD Anderson West Houston, Houston
MD Anderson in The Woodlands, Conroe
MD Anderson in Sugar Land, Sugar Land
MD Anderson League City, League City
Mayo Clinic in Arizona, Scottsdale
Fred Hutch/University of Washington Cancer Consortium, Seattle
Massachusetts General Hospital Cancer Center, Boston
National Cancer Institute (NCI)
NIH
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
M.D. Anderson Cancer Center
OTHER